|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of random- ized clinical trials显示文摘 | Hemmingsen B Lund SS Gluud C | 2011 | BMJ2011，343，： | 1 |
| 2 | Impact of metformin versus repaglinide on non-glyeaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes 显示文摘 | Lund SS Tarnow L Stehouwer CD | 2008 | Eur J E ndocrinol2008，158，5： | 1 |
| 3 | Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial显示文摘 | Lund SS Tarnow L Frandsen M | 2009 | Bri Med J2009，339，： | 1 |
| 4 | Intensive glycae- mic control for patients with type 2 diabetes: systematic review with recta-analysis and trial sequential analysis of randomised clinical trials显示文摘 | Hemmingsen B Lund SS Gluud C | 2011 | Bmj2011，343，： | 1 |
| 5 | Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials显示文摘 | Hemmingsen B Lund SS Gluud C | 2012 | BMJ2012，344，： | 1 |
| 6 | Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes显示文摘 | Lund SS Tarnow L Stehouwer CD | 2008 | Eur J Endocrinol2008，158，3： | 1 |
| 7 | The negative effect of triple-negative breast cancer on outcome after breastconserving therapy显示文摘 | Zaky SS Lund M May KA | 2011 | Ann Surg Oncol2011，18，： | 1 |
| 8 | Insulin initiation in patients with type 2 diabetesmellitus : treatment guidelines,clinical evidence and patterns of useof basal vs premixed insulin analogues显示文摘 | Vaag A Lund SS | 2012 | Eur J Endocrinol2012，166，2： | 1 |
| 9 | Impact of metformin versus repaglinide on non-glycaemic cardio- vascular risk markers related to inflammation and endo- thelial dysfunction in non-obese patients with type 2 di- abetes显示文摘 | Lund SS Tarnow L Stehouwer CD | 2008 | Eur J Endocrinol2008，158，5： | 1 |
| 10 | Triple negative breast cancer confers Higher recurrence rates after breast conserving therapy显示文摘 | Zaky SS Lund M May KA etal | 2008 | 1 nt J Radi- at Oneol Bio Phys2008，72，1： | 1 |
| 11 | Indomethacin as an analgesic after hysterectomy显示文摘 | Engel C Lund B Kristensen SS | 1989 | Acta Anaesthesiol Scand1989，33，6： | 1 |
| 12 | Impact of metfornfin versus the prandial insulin secretagogue, repaglinide, on fasting and post- prandial glucose and lipid responses in non-obese patients with type 2 diabetes显示文摘 | Lund SS Tarnow L Frandsen M | 2008 | Eur J Endocrinol2008，158，1： | 1 |
| 13 | Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in nonobese patients with type 2 dia betes 显示文摘 | Lund SS Tarnow L Frandsen M | 2008 | Eur J Endocrinol2008，158，1： | 1 |
| 14 | Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non- obese patients with type 2 diabetes 显示文摘 | Lund SS Tarnow L Frandsen M | 2008 | European journal of endocrinology2008，158，1： | 1 |
| 15 | Intensive glycaemic control for patients with type 2 diabetes:systematic review with meta-analysis and trial sequential analysis of randomised clinical trials显示文摘 | Hemmingsen B Lund SS Gluud C | 2011 | BMJ:British Medical Journal2011，343，： | 1 |
| 16 | Impact of met- formin versus the prandial insulin secretagogue, repaglin- ide,on fasting and postprandial glucose and lipid respon- ses in non-obese patients with type 2 diabetes显示文摘 | Lund SS Tarnow L Frandsen M | 2008 | Eur J Endocrinol2008，158，1： | 1 |
| 17 | Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials显示文摘 | Hemmingsen B Lund SS Gluud C | 2011 | BMJ2011，343，： | 1 |
| 18 | Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes:12 month,randomised,double blind trial显示文摘 | Lund SS Tarnow L Frandsen M | 2009 | BMJ2009，339，： | 1 |
| 19 | Efficacy and safety of BIAsp 30(Biphasic insulin aspart 30)TID in combination with oral hypoglycaemic agents in non-obese patients with type 2 diabetes显示文摘 | Lund SS Tarnow L Nielsen BB | | 0，，： | 1 |
| 20 | Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in nonobese patients with type 2 dia- betes显示文摘 | Lund SS Tarnow L Frandsen M | 2008 | Eur J Endocrinol2008，158，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员